DK0840603T3 - Farmaceutisk præparat af L-dopa-ethylester - Google Patents
Farmaceutisk præparat af L-dopa-ethylesterInfo
- Publication number
- DK0840603T3 DK0840603T3 DK96923037T DK96923037T DK0840603T3 DK 0840603 T3 DK0840603 T3 DK 0840603T3 DK 96923037 T DK96923037 T DK 96923037T DK 96923037 T DK96923037 T DK 96923037T DK 0840603 T3 DK0840603 T3 DK 0840603T3
- Authority
- DK
- Denmark
- Prior art keywords
- ethyl ester
- pharmaceutical preparation
- dopa ethyl
- dopa
- carrier
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US136895P | 1995-07-21 | 1995-07-21 | |
PCT/IL1996/000058 WO1997003662A1 (en) | 1995-07-21 | 1996-07-18 | Pharmaceutical composition of l-dopa ethyl ester |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0840603T3 true DK0840603T3 (da) | 2003-01-20 |
Family
ID=21695690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96923037T DK0840603T3 (da) | 1995-07-21 | 1996-07-18 | Farmaceutisk præparat af L-dopa-ethylester |
Country Status (12)
Country | Link |
---|---|
US (1) | US5840756A (da) |
EP (1) | EP0840603B1 (da) |
JP (1) | JPH11509547A (da) |
AT (1) | ATE223712T1 (da) |
AU (1) | AU6368596A (da) |
CA (1) | CA2227208A1 (da) |
DE (1) | DE69623634T2 (da) |
DK (1) | DK0840603T3 (da) |
ES (1) | ES2184881T3 (da) |
IL (1) | IL123010A (da) |
PT (1) | PT840603E (da) |
WO (1) | WO1997003662A1 (da) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1329487A (zh) * | 1998-11-10 | 2002-01-02 | 特瓦制药工业有限公司 | 包含l-多巴乙酯的可分散组合物 |
US7674480B2 (en) * | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
US6476006B2 (en) | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
US6881420B2 (en) * | 2000-06-23 | 2005-04-19 | Teva Pharmaceutical Industries Ltd. | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
GB0114198D0 (en) * | 2001-06-11 | 2001-08-01 | Syngenta Ltd | Herbicidal composition |
IL159813A0 (en) * | 2001-07-12 | 2004-06-20 | Teva Pharma | Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release core |
US20030091634A1 (en) * | 2001-09-14 | 2003-05-15 | Pawan Seth | Delayed release tablet of venlafaxin |
WO2003042136A2 (en) * | 2001-11-13 | 2003-05-22 | Teva Pharmaceutical Industries, Ltd. | Process for the production of l-dopa ethyl ester |
AU2002340470A1 (en) | 2001-11-13 | 2003-05-26 | Teva Pharmaceutical Industries, Ltd. | L-dopa ethyl ester salts and uses thereof |
US7101912B2 (en) | 2002-12-06 | 2006-09-05 | Xenoport, Inc. | Carbidopa prodrugs and derivatives, and compositions and uses thereof |
CA2553156A1 (en) * | 2003-10-20 | 2005-05-12 | Teva Pharmaceutical Industries Ltd. | Composition and dosage form for sustained effect of levodopa |
NZ551511A (en) * | 2004-06-04 | 2010-09-30 | Xenoport Inc | Levodopa prodrugs, and compositions and uses thereof |
US7323585B2 (en) * | 2004-06-04 | 2008-01-29 | Xenoport, Inc. | Levodopa prodrugs, and compositions and uses thereof |
NZ560826A (en) * | 2005-03-28 | 2009-06-26 | Orexo Ab | Composition comprising weak acid and particulate L-dopa useful in the treatment of parkinson's disease |
CA2613631A1 (en) * | 2005-06-23 | 2007-01-04 | Spherics, Inc. | Improved dosage forms for movement disorder treatment |
AR055106A1 (es) * | 2005-08-05 | 2007-08-08 | Osmotica Pharmaceutical Argent | Composicion farmaceutica solida de liberacion extendida que contiene carbidopa y levodopa |
WO2007056570A2 (en) * | 2005-11-07 | 2007-05-18 | Teva Pharmaceutical Industries Ltd. | Levodopa compositions |
JP5153641B2 (ja) * | 2005-12-05 | 2013-02-27 | ゼノポート,インコーポレーテッド | レボドパプロドラッグメシラート、その組成物、およびその使用法 |
US20080131492A1 (en) * | 2006-06-23 | 2008-06-05 | Spherics, Inc. | Dosage forms for movement disorder treatment |
TW200843731A (en) * | 2006-12-21 | 2008-11-16 | Xenoport Inc | Catechol protected levodopa diester prodrugs, compositions, and methods of use |
US7709527B2 (en) * | 2006-12-21 | 2010-05-04 | Xenoport, Inc. | Levodopa dimethyl-substituted diester prodrugs compositions, and methods of use |
CA2673511A1 (en) * | 2006-12-22 | 2008-07-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
AU2008343787B2 (en) | 2007-12-28 | 2014-01-30 | Impax Laboratories, Llc | Controlled release formulations of levodopa and uses thereof |
US8399513B2 (en) * | 2008-10-20 | 2013-03-19 | Xenoport, Inc. | Levodopa prodrug mesylate hydrate |
EP2349973A2 (en) * | 2008-10-20 | 2011-08-03 | XenoPort, Inc. | Methods of synthesizing a levodopa ester prodrug |
JP2013520521A (ja) | 2009-11-09 | 2013-06-06 | ゼノポート,インコーポレーテッド | レボドパプロドラッグの医薬組成物及び経口剤形並びに使用方法 |
TR201204839A2 (tr) | 2012-04-25 | 2012-12-21 | Ali̇ Rai̇f İlaç Sanayi̇ A.Ş. | Uzatılmış salım sağlayan levodopa karbıdopa entakapon içeren tablet formülasyonu. |
MX369315B (es) | 2013-10-07 | 2019-11-05 | Impax Laboratories Inc | Formulaciones muco-adhesivas de liberacion controlada de levodopa y/o esteres de levodopa y sus usos. |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
KR20180004756A (ko) | 2015-05-06 | 2018-01-12 | 신애질 코포레이션 | 약물 입자를 함유하는 제약 현탁액, 그의 투여를 위한 장치, 및 그의 사용 방법 |
JP7066351B2 (ja) * | 2017-08-18 | 2022-05-13 | 大原薬品工業株式会社 | 良好な徐放性を有する、レボドパ含有小型化錠剤 |
US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4259314A (en) * | 1979-12-10 | 1981-03-31 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals |
US4424235A (en) * | 1981-09-14 | 1984-01-03 | Hoffmann-La Roche Inc. | Hydrodynamically balanced controlled release compositions containing L-dopa and a decarboxylase inhibitor |
CH652025A5 (de) * | 1981-09-14 | 1985-10-31 | Hoffmann La Roche | Pharmazeutisches praeparat. |
US4680323A (en) * | 1983-12-01 | 1987-07-14 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration |
US5354885A (en) * | 1992-12-24 | 1994-10-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Process for preparing ethyl ester of L-DOPA |
US5607969A (en) * | 1992-12-24 | 1997-03-04 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | L-DOPA ethyl ester to treat Parkinson's disease |
-
1996
- 1996-07-11 US US08/678,716 patent/US5840756A/en not_active Expired - Lifetime
- 1996-07-18 JP JP9506517A patent/JPH11509547A/ja not_active Withdrawn
- 1996-07-18 DK DK96923037T patent/DK0840603T3/da active
- 1996-07-18 WO PCT/IL1996/000058 patent/WO1997003662A1/en active IP Right Grant
- 1996-07-18 DE DE69623634T patent/DE69623634T2/de not_active Expired - Fee Related
- 1996-07-18 CA CA002227208A patent/CA2227208A1/en not_active Abandoned
- 1996-07-18 ES ES96923037T patent/ES2184881T3/es not_active Expired - Lifetime
- 1996-07-18 PT PT96923037T patent/PT840603E/pt unknown
- 1996-07-18 IL IL12301096A patent/IL123010A/xx not_active IP Right Cessation
- 1996-07-18 AT AT96923037T patent/ATE223712T1/de not_active IP Right Cessation
- 1996-07-18 AU AU63685/96A patent/AU6368596A/en not_active Abandoned
- 1996-07-18 EP EP96923037A patent/EP0840603B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
IL123010A (en) | 2003-11-23 |
DE69623634D1 (de) | 2002-10-17 |
IL123010A0 (en) | 1998-08-16 |
ATE223712T1 (de) | 2002-09-15 |
EP0840603B1 (en) | 2002-09-11 |
EP0840603A1 (en) | 1998-05-13 |
JPH11509547A (ja) | 1999-08-24 |
AU6368596A (en) | 1997-02-18 |
DE69623634T2 (de) | 2003-05-22 |
PT840603E (pt) | 2003-01-31 |
WO1997003662A1 (en) | 1997-02-06 |
CA2227208A1 (en) | 1997-02-06 |
ES2184881T3 (es) | 2003-04-16 |
US5840756A (en) | 1998-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0840603T3 (da) | Farmaceutisk præparat af L-dopa-ethylester | |
EA199900937A1 (ru) | Фармацевтические композиции, содержащие вориконазол | |
SE9504661D0 (sv) | New compounds | |
PT951474E (pt) | Novos derivados da ciclosporina sua preparacao e composicoes farmaceuticas que os contem | |
ATE306261T1 (de) | Antithrombosemittel | |
DE69830504D1 (de) | Antithrombotische mitteln | |
BR9809112A (pt) | Novo processo para preparação de uma substância farmacologicamente ativa | |
DK0869808T3 (da) | Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation | |
CY1107874T1 (el) | Φαρμακευτικh σyνθεση επιβραδυνoμενης αποδεσμευσης φλουβαστατiνης | |
AU1557595A (en) | Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents | |
ATE260658T1 (de) | Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen | |
SE9602442D0 (sv) | Administration of pharmaceuticals | |
DE69434652D1 (de) | Antikonvulsive pseudofructopyranose sulfamate | |
DE69616074D1 (de) | Ara-c derivate | |
HUP9701660A2 (hu) | 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények | |
NO982229D0 (no) | Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler | |
SE9504662D0 (sv) | New compounds | |
TR199700963T1 (xx) | Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi. | |
MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
PT989994E (pt) | Derivados de estreptograminas, a sua preparacao e as composicoes que os contem | |
TR200002293T2 (tr) | Farmasötik bileşimler. | |
BR9813102A (pt) | Derivados de ácido metilenobisfosfÈnico novos | |
DE69614552D1 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE | |
TR200100887T2 (tr) | LH-RH analoglarının ağız yoluyla verilmesi için alfa-siklodekstrin esaslı farmasötik terkipler | |
BR0016737A (pt) | 14,15-ciclopropano-androstanos insaturados, processos para a sua preparação e composições farmacêuticas contendo estes compostos |